Portal de Periódicos da CAPES

Patient Blood Management

2016; Lippincott Williams & Wilkins; Volume: 264; Issue: 2 Linguagem: Inglês

10.1097/sla.0000000000001787

1528-1140

Donat R. Spahn,

Organ Donation and Transplantation

Institute of Anesthesiology, University and University Hospital of Zurich, Zurich, Switzerland. Reprints: Donat R. Spahn, MD, FRCA Professor and Chairman Institute of Anesthesiology Section Head Medical Anesthesiology - Intensive Care Medicine - OR-Management University of Zurich and University Hospital Zurich Raemistrasse 100 CH-8091 Zurich, Switzerland. E-mail: [email protected]. Conflict of interest statement (past 5 years): Donat R. Spahn—Dr Spahn's academic department is/has been receiving grant support from the Swiss National Science Foundation, Berne, Switzerland, the Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland for Highly Specialized Medicine, the Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland, the Swiss Foundation for Anesthesia Research, Zurich, Switzerland, Bundesprogramm Chancengleichheit, Berne, Switzerland, CSL Behring, Berne, Switzerland, Vifor SA, Villars-sur-Glâne, Switzerland. Dr Spahn was the chair of the ABC Faculty and is the co-chair of the ABC-Trauma Faculty, managed by Physicians World Europe GmbH, Mannheim, Germany and sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland, CSL Behring GmbH, Marburg, Germany and LFB Biomédicaments, Courtaboeuf Cedex, France. In the past 5 years, Dr Spahn has received honoraria or travel support for consulting or lecturing from: Abbott AG, Baar, Switzerland, AMGEN GmbH, Munich, Germany, AstraZeneca AG, Zug, Switzerland, Baxter AG, Volketswil, Switzerland,Baxter S.p.A., Roma, Italy, Bayer, Zürich, Switzerland and Berlin, Germany, B. Braun Melsungen AG, Melsungen, Germany, Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland, Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland, CSL Behring GmbH, Hattersheim am Main, Germany and Berne, Switzerland, Curacyte AG, Munich, Germany, Daiichi Sankyo (Schweiz) AG, Thalwil, Switzerland, Ethicon Biosurgery, Sommerville, New Jersey, USA, Fresenius SE, Bad Homburg v.d.H., Germany, Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Glâne, Switzerland),GlaxoSmithKline GmbH & Co. KG, Hamburg, Germany, Janssen-Cilag, Baar, Switzerland and Beerse, Belgium, LFB Biomédicaments, Courtaboeuf Cedex, France, Merck Sharp & Dohme AG, Luzern, Switzerland, Novo Nordisk A/S, Bagsvärd, Denmark, Octapharma AG, Lachen, Switzerland, Organon AG, Pfäffikon/SZ, Switzerland, PAION Deutschland GmbH, Aachen, Germany, Pharmacosmos A/S, Holbaek, Denmark,Photonics Healthcare B.V., Utrecht, Netherlands, ratiopharm Arzneimittel Vertriebs-GmbH, Vienna, Austria, Roche, Reinach, Switzerland, Schering-Plough International, Inc., Kenilworth, New Jersey, USA, Tem International GmbH, Munich, Germany, Verum Diagnostica GmbH, Munich, Germany, Vifor Pharma, Munich, Germany, Vienna, Austria and St. Gallen, Switzerland.